Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Barbara Dietrich"'
Autor:
Apostolos Chatzitomaris, Rudolf Hoermann, John E. Midgley, Steffen Hering, Aline Urban, Barbara Dietrich, Assjana Abood, Harald H. Klein, Johannes W. Dietrich
Publikováno v:
Frontiers in Endocrinology, Vol 8 (2017)
The hypothalamus–pituitary–thyroid feedback control is a dynamic, adaptive system. In situations of illness and deprivation of energy representing type 1 allostasis, the stress response operates to alter both its set point and peripheral transfer
Externí odkaz:
https://doaj.org/article/4de0d4dba104425392608b3d187ba5d7
Autor:
Andrea Beyerle, Bronwyn A. Kingwell, Samuel D. Wright, Brandon H Greene, Priya Panjwani, Eva Herzog, Barbara Dietrich
Publikováno v:
Toxicology and Applied Pharmacology. 422:115557
CSL112 (apolipoprotein A-I, apo AI [human]) is an investigational drug in Phase 3 development for risk reduction of early recurrent cardiovascular events following an acute myocardial infarction (AMI). Although CSL112 is known to be well tolerated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73562a20a51703434e87a7383fc35af0
https://doi.org/10.1016/j.taap.2021.115557
https://doi.org/10.1016/j.taap.2021.115557
Autor:
Srilatha D Tangada, Eva-Maria Muchitsch, Gerald Schrenk, Borislava G. Pavlova, Werner Höllriegl, Frank M. Horling, Peter Turecek, Artur Mitterer, Hanspeter Rottensteiner, Brigitt Abbühl, Herbert Gritsch, Barbara Dietrich, Alexandra Schiviz, Birgit M. Reipert, Miranda Chapman, Friedrich Scheiflinger
Publikováno v:
Expert Review of Clinical Pharmacology. 8:163-177
Nonacog gamma is a new recombinant factor IX to treat factor IX deficiency. It is indicated for control of bleeding episodes, perioperative management and routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f121c97b294f19bb4b16fb333eba481f
https://doi.org/10.1586/17512433.2015.1011126
https://doi.org/10.1586/17512433.2015.1011126
Autor:
Barbara Dietrich
Publikováno v:
DO - Deutsche Zeitschrift für Osteopathie. 11:14-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b582f0c1a39626b3169d9ca0160094a9
https://doi.org/10.1055/s-0032-1328011
https://doi.org/10.1055/s-0032-1328011
Autor:
Barbara Dietrich
Publikováno v:
Deutsche Heilpraktiker-Zeitschrift. 7:64-67
Menschen, die in ihrer Vergangenheit sexuelle Gewalt erlebt haben, sind meistens stark traumatisiert. Mit schwerwiegenden und langwierigen Auswirkungen auf Korper und Psyche. Es ist eine heikle Aufgabe, solche Patientinnen und Patienten zu begleiten.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77b41a27227b4a6da054d0f65f4a767f
https://doi.org/10.1055/s-0032-1330252
https://doi.org/10.1055/s-0032-1330252
Autor:
Barbara Dietrich
Publikováno v:
DO - Deutsche Zeitschrift für Osteopathie. 10:21-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4357cce92bce777c7f4706513d3df497
https://doi.org/10.1055/s-0031-1298557
https://doi.org/10.1055/s-0031-1298557
Publikováno v:
Toxicology and Applied Pharmacology. 240:117-122
Statistical comparison of organ weights between treated and untreated animals have traditionally been used to predict potential toxicity for patients. The manner of presentation of organ weight data, and the value of statistical analyses have been to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd292235f74a4cfb600681deb5e47a3
https://doi.org/10.1016/j.taap.2009.06.012
https://doi.org/10.1016/j.taap.2009.06.012
Autor:
Gerald Hoebarth, Peter Leidenmuehler, Veronika Ehrlich, Peter Turecek, Barbara Dietrich, Werner Hoellriegl, Herbert Gritsch, Alfred Weber, Tanja Ruthsatz, Marietta Turecek, Martin J. Wolfsegger
Publikováno v:
Blood. 128:4977-4977
Hemophilia A is a rare genetic bleeding disorder caused by missing or defective factor VIII (FVIII), a crucial factor in blood coagulation. Baxalta Innovations / Shire is currently developing SHP 826 (BAX 826), as the next generation EHL rFVIII repla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::453b04f669026cc6b01944b1208a5ab6
https://doi.org/10.1182/blood.v128.22.4977.4977
https://doi.org/10.1182/blood.v128.22.4977.4977
Autor:
Frank M. Horling, Friedrich Scheiflinger, Peter Turecek, Eva-Maria Muchitsch, Alexandra Schiviz, Karima Benamara, Hans Peter Schwarz, Barbara Dietrich, Hanspeter Rottensteiner, Werner Hoellriegl
Publikováno v:
International Journal of Hematology
Baxter has developed a new recombinant factor IX (rFIX) drug product (BAX326) for treating patients with hemophilia B, or congenital FIX deficiency. An extensive preclinical program evaluated the pharmacokinetics, efficacy, and safety of BAX326 in di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f023882f53f23a04e730355007db3ac4
https://pubmed.ncbi.nlm.nih.gov/24061775
https://pubmed.ncbi.nlm.nih.gov/24061775